Hemorrhage Postoperative
7
1
1
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
14.3%
1 terminated out of 7 trials
75.0%
-11.5% vs benchmark
29%
2 trials in Phase 3/4
67%
2 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
Safe and Timely Antithrombotic Removal (STAR) Registry
Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D)
Developing an Intervention to Improve the Non-Technical Skills of the Cardiac Surgical Teams
Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T)
Stratafix Vs. Vicryl OAGB / MGB Suture Study
Noninferiority Oral Tranexamic Acid vs Intravenous Administration in Total Hip Arthroplasty
Oral Administration of Tranexamic Acid in Anterior Cruciate Ligament Surgery Reduce Postoperative Haemarthrosis